MDPI and ACS Style
Pető, Á.; Kósa, D.; Haimhoffer, Á.; Fehér, P.; Ujhelyi, Z.; Sinka, D.; Fenyvesi, F.; Váradi, J.; Vecsernyés, M.; Gyöngyösi, A.;
et al. Nicotinic Amidoxime Derivate BGP-15, Topical Dosage Formulation and Anti-Inflammatory Effect. Pharmaceutics 2021, 13, 2037.
https://doi.org/10.3390/pharmaceutics13122037
AMA Style
Pető Á, Kósa D, Haimhoffer Á, Fehér P, Ujhelyi Z, Sinka D, Fenyvesi F, Váradi J, Vecsernyés M, Gyöngyösi A,
et al. Nicotinic Amidoxime Derivate BGP-15, Topical Dosage Formulation and Anti-Inflammatory Effect. Pharmaceutics. 2021; 13(12):2037.
https://doi.org/10.3390/pharmaceutics13122037
Chicago/Turabian Style
Pető, Ágota, Dóra Kósa, Ádám Haimhoffer, Pálma Fehér, Zoltán Ujhelyi, Dávid Sinka, Ferenc Fenyvesi, Judit Váradi, Miklós Vecsernyés, Alexandra Gyöngyösi,
and et al. 2021. "Nicotinic Amidoxime Derivate BGP-15, Topical Dosage Formulation and Anti-Inflammatory Effect" Pharmaceutics 13, no. 12: 2037.
https://doi.org/10.3390/pharmaceutics13122037